Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Amanta HealthcareNSE:AMANTA -2.00%26 OCF Margin % is 0.00% as of Mar. 2026. GuruFocus rates NSE:AMANTA with a GF Score™ of 26/100. The stock has 4 warning signs investors should review. Among 964 Drug Manufacturers companies, Amanta Healthcare ranks better than 79.98% on this metric.
The historical rank and industry rank for Amanta Healthcare's OCF Margin % or its related term are showing as below:
NSE:AMANTA'
s OCF Margin % Range Over the Past 10 Years
Min: 16.53 Med: 16.97 Max: 28.36
Current: 21.79
During the past 5 years, the highest OCF Margin % of Amanta Healthcare was 28.36%. The lowest was 16.53%. And the median was 16.97%.
NSE:AMANTA's OCF Margin % is ranked better than 79.98% of 964
companies
in the Drug Manufacturers industry
Industry Median: 10.035
vs NSE:AMANTA: 21.79
Amanta Healthcare OCF Margin % Related Terms
Amanta Healthcare OCF Margin % Historical Data
* Premium members only.
The historical data trend for Amanta Healthcare's OCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Amanta Healthcare's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Amanta Healthcare OCF Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Amanta Healthcare's OCF Margin % distribution charts can be found below:
* The bar in red indicates where Amanta Healthcare's OCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Amanta Healthcare (NSE:AMANTA) has a OCF Margin % of 0.00% as of Mar. 2026. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Amanta Healthcare and its competitors. Over the past decade, Amanta Healthcare's OCF Margin % has ranged from 16.53 to 28.36. According to the industry distribution chart, Amanta Healthcare ranks #193 out of 964 companies in the Drug Manufacturers industry, placing it in the top 20%.
Is Amanta Healthcare's OCF Margin % too high?
Amanta Healthcare's current OCF Margin % is 0.00%. Over the past 10 years, this metric has ranged from a low of 16.53 to a high of 28.36. Based on the distribution chart, Amanta Healthcare ranks #193 out of 964 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Amanta Healthcare has a GF Score™ of 26/100, reflecting its overall financial health beyond just this single metric.
How does Amanta Healthcare's OCF Margin % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Amanta Healthcare ranks #193 out of 964 companies for OCF Margin %. This places Amanta Healthcare in the top 20% of its industry — outperforming the majority of peers. The industry median OCF Margin % is 10.04. Historically, Amanta Healthcare's own OCF Margin % has ranged from 16.53 to 28.36 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Drug Manufacturers company?
The median OCF Margin % among Drug Manufacturers companies is 10.04, based on 964 companies in the industry. Companies in the top quartile (top 25%) have a OCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Amanta Healthcare and its competitors. For the Drug Manufacturers industry, the median OCF Margin % is 10.04 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Amanta Healthcare's current OCF Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Amanta Healthcare stock overvalued right now?
Amanta Healthcare (NSE:AMANTA) has a current OCF Margin % of 0.00%. The current OCF Margin % is 0.00%. Amanta Healthcare's overall GF Score™ is 26/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For Amanta Healthcare (NSE:AMANTA), the current OCF Margin % is 0.00% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Amanta Healthcare Ltd is a pharmaceutical company engaged in developing, manufacturing and marketing a diverse range of sterile liquid products - parenteral products, being packed in plastic container with Aseptic Blow-Fill-Seal and Injection Strech Blow Moulding technology. It manufactures large volume parenterals and small volume parenterals in six therapeutic segments. It also manufactures medical devices. The company manufactures fluid therapy, formulations, diluents, ophthalmic, respiratory care and irrigation solutions in therapeutic segment and products like irrigation, first-aid solution, eye lubricants etc. in medical device segment. It offers wide range of closure systems, such as nipple head, twist-off, leur-lock and screw types and container fill-volume till 1000 ml.
26GF Score
Get the complete analysis for NSE:AMANTA
OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:AMANTA has been successfully added to your 
